Loading…

1H‐1,2,3‐triazole embedded Isatin‐Benzaldehyde‐bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation

Rapid growth of global drug‐resistant tuberculosis and urgent requirement for short treatment regimens is stimulating the need for discovery of new TB drugs. In this work, we report the design, synthesis and in vitro antimycobacterial evaluation of a library of isatin‐derived bis(heteronuclear hydra...

Full description

Saved in:
Bibliographic Details
Published in:Chemical biology & drug design 2022-02, Vol.99 (2), p.301-307
Main Authors: Sharma, Bharvi, Kumar, Sumit, Preeti, Johansen, Matt D., Kremer, Laurent, Kumar, Vipan
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 307
container_issue 2
container_start_page 301
container_title Chemical biology & drug design
container_volume 99
creator Sharma, Bharvi
Kumar, Sumit
Preeti
Johansen, Matt D.
Kremer, Laurent
Kumar, Vipan
description Rapid growth of global drug‐resistant tuberculosis and urgent requirement for short treatment regimens is stimulating the need for discovery of new TB drugs. In this work, we report the design, synthesis and in vitro antimycobacterial evaluation of a library of isatin‐derived bis(heteronuclear hydrazones). Evaluation results revealed that the inclusion of isoniazid core into 1H‐1,2,3‐triazole tethered isatin‐benzaldehydes improved the antimycobacterial activity on tuberculosis mc26230 strain and significantly reduced the cytotoxicity against Vero cells. However, the introduction of semicarbazones/thiosemicarbazones or pyrazine‐2‐carbohydrazide produced the opposite effects. The compounds with isoniazid and polar‐donating groups at the C‐5 position of isatin emerged as the most promising conjugates with MIC99 = 0.36 µg/ml. The most active compounds were non‐cytotoxic to Vero cells (IC50>100 µg/ml) with selectivity indices >277. Isatin‐benzaldehyde‐bis(heteronuclear hydrazones) were synthesized and evaluated as anti‐mycobacterials. The introduction of isoniazid improved the activity and reduced cytotoxicity. The most promising and non‐cytotoxic conjugates 14c and 14e exhibited MIC99 0.36 µg/ml. The most potent conjugate demonstrated a selectivity index > 277.
doi_str_mv 10.1111/cbdd.13984
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2598535976</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2598535976</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2534-a3980dde5783e283ff5060ff17654a0bd25cfe76b0f89754f055fbf0d8db66f03</originalsourceid><addsrcrecordid>eNo9UctOwzAQtBCI8rrwAShHkFqw4zh2udHylJC4wDmy4zU1cpwSJ0B64hOQ-EO-BJcCe9nx7sza3kFon-BjEuOkVFofEzoW2RraIjzjI5wKtv6POR-g7RCeMM4ylopNNKAZF7nI0y30Sa6_3j_IMB3SmNvGykXtIIFKgdagk5sgW-tjawJ-IZ2GWa8hHpUNhzNooal9VzqQTaw3UeshHJ0mGoJ99MMk9L6dRRyGifStrfqyVrKMKivdsqSTsm_rtn6zZQIv0nXxstrvog0jXYC937yDHi4v7qfXo9u7q5vp2e1onjKajWT8MY6PZFxQSAU1huEcG0N4zjKJlU5ZaYDnChsx5iwzmDGjDNZCqzw3mO6gw9XceVM_dxDaorKhBOekh7oLRcrGglE25nmkHvxSO1WBLuaNrWTTF3-LjASyIrxaB_1_n-BiaVGxtKj4saiYTs7PfxD9BleXipg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2598535976</pqid></control><display><type>article</type><title>1H‐1,2,3‐triazole embedded Isatin‐Benzaldehyde‐bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Sharma, Bharvi ; Kumar, Sumit ; Preeti ; Johansen, Matt D. ; Kremer, Laurent ; Kumar, Vipan</creator><creatorcontrib>Sharma, Bharvi ; Kumar, Sumit ; Preeti ; Johansen, Matt D. ; Kremer, Laurent ; Kumar, Vipan</creatorcontrib><description>Rapid growth of global drug‐resistant tuberculosis and urgent requirement for short treatment regimens is stimulating the need for discovery of new TB drugs. In this work, we report the design, synthesis and in vitro antimycobacterial evaluation of a library of isatin‐derived bis(heteronuclear hydrazones). Evaluation results revealed that the inclusion of isoniazid core into 1H‐1,2,3‐triazole tethered isatin‐benzaldehydes improved the antimycobacterial activity on tuberculosis mc26230 strain and significantly reduced the cytotoxicity against Vero cells. However, the introduction of semicarbazones/thiosemicarbazones or pyrazine‐2‐carbohydrazide produced the opposite effects. The compounds with isoniazid and polar‐donating groups at the C‐5 position of isatin emerged as the most promising conjugates with MIC99 = 0.36 µg/ml. The most active compounds were non‐cytotoxic to Vero cells (IC50&gt;100 µg/ml) with selectivity indices &gt;277. Isatin‐benzaldehyde‐bis(heteronuclear hydrazones) were synthesized and evaluated as anti‐mycobacterials. The introduction of isoniazid improved the activity and reduced cytotoxicity. The most promising and non‐cytotoxic conjugates 14c and 14e exhibited MIC99 0.36 µg/ml. The most potent conjugate demonstrated a selectivity index &gt; 277.</description><identifier>ISSN: 1747-0277</identifier><identifier>EISSN: 1747-0285</identifier><identifier>DOI: 10.1111/cbdd.13984</identifier><identifier>PMID: 34786862</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; antimycobacterial ; Antitubercular Agents - chemical synthesis ; Antitubercular Agents - chemistry ; Antitubercular Agents - pharmacology ; Benzaldehydes - chemistry ; Chlorocebus aethiops ; cytotoxicity ; Drug Design - methods ; Hydrazones - chemistry ; Isatin - chemistry ; Isatin‐heteronuclear hydrazones ; Microbial Sensitivity Tests ; Mycobacterium tuberculosis ; Mycobacterium tuberculosis - drug effects ; schiff bases ; Structure-Activity Relationship ; Triazoles - chemical synthesis ; Triazoles - chemistry ; Triazoles - pharmacology ; Vero Cells</subject><ispartof>Chemical biology &amp; drug design, 2022-02, Vol.99 (2), p.301-307</ispartof><rights>2021 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-6164-7161</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34786862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharma, Bharvi</creatorcontrib><creatorcontrib>Kumar, Sumit</creatorcontrib><creatorcontrib>Preeti</creatorcontrib><creatorcontrib>Johansen, Matt D.</creatorcontrib><creatorcontrib>Kremer, Laurent</creatorcontrib><creatorcontrib>Kumar, Vipan</creatorcontrib><title>1H‐1,2,3‐triazole embedded Isatin‐Benzaldehyde‐bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation</title><title>Chemical biology &amp; drug design</title><addtitle>Chem Biol Drug Des</addtitle><description>Rapid growth of global drug‐resistant tuberculosis and urgent requirement for short treatment regimens is stimulating the need for discovery of new TB drugs. In this work, we report the design, synthesis and in vitro antimycobacterial evaluation of a library of isatin‐derived bis(heteronuclear hydrazones). Evaluation results revealed that the inclusion of isoniazid core into 1H‐1,2,3‐triazole tethered isatin‐benzaldehydes improved the antimycobacterial activity on tuberculosis mc26230 strain and significantly reduced the cytotoxicity against Vero cells. However, the introduction of semicarbazones/thiosemicarbazones or pyrazine‐2‐carbohydrazide produced the opposite effects. The compounds with isoniazid and polar‐donating groups at the C‐5 position of isatin emerged as the most promising conjugates with MIC99 = 0.36 µg/ml. The most active compounds were non‐cytotoxic to Vero cells (IC50&gt;100 µg/ml) with selectivity indices &gt;277. Isatin‐benzaldehyde‐bis(heteronuclear hydrazones) were synthesized and evaluated as anti‐mycobacterials. The introduction of isoniazid improved the activity and reduced cytotoxicity. The most promising and non‐cytotoxic conjugates 14c and 14e exhibited MIC99 0.36 µg/ml. The most potent conjugate demonstrated a selectivity index &gt; 277.</description><subject>Animals</subject><subject>antimycobacterial</subject><subject>Antitubercular Agents - chemical synthesis</subject><subject>Antitubercular Agents - chemistry</subject><subject>Antitubercular Agents - pharmacology</subject><subject>Benzaldehydes - chemistry</subject><subject>Chlorocebus aethiops</subject><subject>cytotoxicity</subject><subject>Drug Design - methods</subject><subject>Hydrazones - chemistry</subject><subject>Isatin - chemistry</subject><subject>Isatin‐heteronuclear hydrazones</subject><subject>Microbial Sensitivity Tests</subject><subject>Mycobacterium tuberculosis</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>schiff bases</subject><subject>Structure-Activity Relationship</subject><subject>Triazoles - chemical synthesis</subject><subject>Triazoles - chemistry</subject><subject>Triazoles - pharmacology</subject><subject>Vero Cells</subject><issn>1747-0277</issn><issn>1747-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo9UctOwzAQtBCI8rrwAShHkFqw4zh2udHylJC4wDmy4zU1cpwSJ0B64hOQ-EO-BJcCe9nx7sza3kFon-BjEuOkVFofEzoW2RraIjzjI5wKtv6POR-g7RCeMM4ylopNNKAZF7nI0y30Sa6_3j_IMB3SmNvGykXtIIFKgdagk5sgW-tjawJ-IZ2GWa8hHpUNhzNooal9VzqQTaw3UeshHJ0mGoJ99MMk9L6dRRyGifStrfqyVrKMKivdsqSTsm_rtn6zZQIv0nXxstrvog0jXYC937yDHi4v7qfXo9u7q5vp2e1onjKajWT8MY6PZFxQSAU1huEcG0N4zjKJlU5ZaYDnChsx5iwzmDGjDNZCqzw3mO6gw9XceVM_dxDaorKhBOekh7oLRcrGglE25nmkHvxSO1WBLuaNrWTTF3-LjASyIrxaB_1_n-BiaVGxtKj4saiYTs7PfxD9BleXipg</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Sharma, Bharvi</creator><creator>Kumar, Sumit</creator><creator>Preeti</creator><creator>Johansen, Matt D.</creator><creator>Kremer, Laurent</creator><creator>Kumar, Vipan</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6164-7161</orcidid></search><sort><creationdate>202202</creationdate><title>1H‐1,2,3‐triazole embedded Isatin‐Benzaldehyde‐bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation</title><author>Sharma, Bharvi ; Kumar, Sumit ; Preeti ; Johansen, Matt D. ; Kremer, Laurent ; Kumar, Vipan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2534-a3980dde5783e283ff5060ff17654a0bd25cfe76b0f89754f055fbf0d8db66f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>antimycobacterial</topic><topic>Antitubercular Agents - chemical synthesis</topic><topic>Antitubercular Agents - chemistry</topic><topic>Antitubercular Agents - pharmacology</topic><topic>Benzaldehydes - chemistry</topic><topic>Chlorocebus aethiops</topic><topic>cytotoxicity</topic><topic>Drug Design - methods</topic><topic>Hydrazones - chemistry</topic><topic>Isatin - chemistry</topic><topic>Isatin‐heteronuclear hydrazones</topic><topic>Microbial Sensitivity Tests</topic><topic>Mycobacterium tuberculosis</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>schiff bases</topic><topic>Structure-Activity Relationship</topic><topic>Triazoles - chemical synthesis</topic><topic>Triazoles - chemistry</topic><topic>Triazoles - pharmacology</topic><topic>Vero Cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharma, Bharvi</creatorcontrib><creatorcontrib>Kumar, Sumit</creatorcontrib><creatorcontrib>Preeti</creatorcontrib><creatorcontrib>Johansen, Matt D.</creatorcontrib><creatorcontrib>Kremer, Laurent</creatorcontrib><creatorcontrib>Kumar, Vipan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical biology &amp; drug design</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharma, Bharvi</au><au>Kumar, Sumit</au><au>Preeti</au><au>Johansen, Matt D.</au><au>Kremer, Laurent</au><au>Kumar, Vipan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1H‐1,2,3‐triazole embedded Isatin‐Benzaldehyde‐bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation</atitle><jtitle>Chemical biology &amp; drug design</jtitle><addtitle>Chem Biol Drug Des</addtitle><date>2022-02</date><risdate>2022</risdate><volume>99</volume><issue>2</issue><spage>301</spage><epage>307</epage><pages>301-307</pages><issn>1747-0277</issn><eissn>1747-0285</eissn><abstract>Rapid growth of global drug‐resistant tuberculosis and urgent requirement for short treatment regimens is stimulating the need for discovery of new TB drugs. In this work, we report the design, synthesis and in vitro antimycobacterial evaluation of a library of isatin‐derived bis(heteronuclear hydrazones). Evaluation results revealed that the inclusion of isoniazid core into 1H‐1,2,3‐triazole tethered isatin‐benzaldehydes improved the antimycobacterial activity on tuberculosis mc26230 strain and significantly reduced the cytotoxicity against Vero cells. However, the introduction of semicarbazones/thiosemicarbazones or pyrazine‐2‐carbohydrazide produced the opposite effects. The compounds with isoniazid and polar‐donating groups at the C‐5 position of isatin emerged as the most promising conjugates with MIC99 = 0.36 µg/ml. The most active compounds were non‐cytotoxic to Vero cells (IC50&gt;100 µg/ml) with selectivity indices &gt;277. Isatin‐benzaldehyde‐bis(heteronuclear hydrazones) were synthesized and evaluated as anti‐mycobacterials. The introduction of isoniazid improved the activity and reduced cytotoxicity. The most promising and non‐cytotoxic conjugates 14c and 14e exhibited MIC99 0.36 µg/ml. The most potent conjugate demonstrated a selectivity index &gt; 277.</abstract><cop>England</cop><pmid>34786862</pmid><doi>10.1111/cbdd.13984</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-6164-7161</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1747-0277
ispartof Chemical biology & drug design, 2022-02, Vol.99 (2), p.301-307
issn 1747-0277
1747-0285
language eng
recordid cdi_proquest_miscellaneous_2598535976
source Wiley-Blackwell Read & Publish Collection
subjects Animals
antimycobacterial
Antitubercular Agents - chemical synthesis
Antitubercular Agents - chemistry
Antitubercular Agents - pharmacology
Benzaldehydes - chemistry
Chlorocebus aethiops
cytotoxicity
Drug Design - methods
Hydrazones - chemistry
Isatin - chemistry
Isatin‐heteronuclear hydrazones
Microbial Sensitivity Tests
Mycobacterium tuberculosis
Mycobacterium tuberculosis - drug effects
schiff bases
Structure-Activity Relationship
Triazoles - chemical synthesis
Triazoles - chemistry
Triazoles - pharmacology
Vero Cells
title 1H‐1,2,3‐triazole embedded Isatin‐Benzaldehyde‐bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T16%3A30%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1H%E2%80%901,2,3%E2%80%90triazole%20embedded%20Isatin%E2%80%90Benzaldehyde%E2%80%90bis(heteronuclearhydrazones):%20design,%20synthesis,%20antimycobacterial,%20and%20cytotoxic%20evaluation&rft.jtitle=Chemical%20biology%20&%20drug%20design&rft.au=Sharma,%20Bharvi&rft.date=2022-02&rft.volume=99&rft.issue=2&rft.spage=301&rft.epage=307&rft.pages=301-307&rft.issn=1747-0277&rft.eissn=1747-0285&rft_id=info:doi/10.1111/cbdd.13984&rft_dat=%3Cproquest_pubme%3E2598535976%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p2534-a3980dde5783e283ff5060ff17654a0bd25cfe76b0f89754f055fbf0d8db66f03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2598535976&rft_id=info:pmid/34786862&rfr_iscdi=true